Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR

Peter Wolf, Alexandre Dormoy, Luigi Maione, Sylvie Salenave, Jacques Young, Peter Kamenický, Philippe Chanson

Open source

DOI
10.1530/ec-22-0296
Published
2022-12-01
Container
Endocrine Connections
Publisher
Bioscientifica
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1530/ec-22-0296,
  title = {Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR},
  author = {Peter Wolf and Alexandre Dormoy and Luigi Maione and Sylvie Salenave and Jacques Young and Peter Kamenický and Philippe Chanson},
  year = {2022},
  journal = {Endocrine Connections},
  doi = {10.1530/ec-22-0296},
  url = {https://doi.org/10.1530/ec-22-0296}
}

RIS

TY  - JOUR
TI  - Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR
AU  - Peter Wolf
AU  - Alexandre Dormoy
AU  - Luigi Maione
AU  - Sylvie Salenave
AU  - Jacques Young
AU  - Peter Kamenický
AU  - Philippe Chanson
PY  - 2022
JO  - Endocrine Connections
DO  - 10.1530/ec-22-0296
UR  - https://doi.org/10.1530/ec-22-0296
ER  - 

APA

Wolf, P., Dormoy, A., Maione, L., Salenave, S., Young, J., Kamenický, P., & Chanson, P. (2022). Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR. Endocrine Connections. https://doi.org/10.1530/ec-22-0296

Source records